Ackerman Capital Advisors LLC Sells 838,856 Shares of Mangoceuticals, Inc. (NASDAQ:MGRX)

Ackerman Capital Advisors LLC reduced its position in shares of Mangoceuticals, Inc. (NASDAQ:MGRX) by 96.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,500 shares of the company’s stock after selling 838,856 shares during the period. Ackerman Capital Advisors LLC owned approximately 1.39% of Mangoceuticals worth $83,000 at the end of the most recent reporting period.

Mangoceuticals Stock Performance

NASDAQ MGRX opened at $4.10 on Wednesday. The firm’s fifty day moving average price is $3.19 and its two-hundred day moving average price is $21.50. The stock has a market cap of $10.21 million, a PE ratio of -0.71 and a beta of 2.02. Mangoceuticals, Inc. has a fifty-two week low of $2.07 and a fifty-two week high of $16.80.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.